Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 2

Natalizumab: A new treatment for relapsing remitting multiple sclerosis

       
Total article views   HTML views PDF downloads Totals
6,599 Dovepress* 6,599+ 2,304 8,903
Totals 6,599 2,304 8,903
*Since 15 May 2007
+Since July 2016

View citations on Google Scholar